Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.

Seymour, John F; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew P; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Sökler, Martin; Dünzinger, Ulrich; Nielsen, Tina; Launonen, Aino; Hiddemann, Wolfgang

doi:10.3324/haematol.2020.246991

Austin Health

Title

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.

Publication Date

2020-05

Author(s)

Seymour, John F

Marcus, Robert

Davies, Andrew

Gallop-Evans, Eve

Grigg, Andrew P

Haynes, Andrew

Herold, Michael

Illmer, Thomas

Nilsson-Ehle, Herman

Sökler, Martin

Dünzinger, Ulrich

Nielsen, Tina

Launonen, Aino

Hiddemann, Wolfgang

Type of document

Journal Article

DOI

10.3324/haematol.2020.246991

Link

link

Citation

Haematologica 2020; 105(5): 1465

Jornal Title

Haematologica

Files:

Name	Size	format	Description	Link